Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 4/20 | 0.64 |
| ▸ | PPARG | P37231 | 2/20 | 0.53 |
| ▸ | PPARA | Q07869 | 2/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.51 |
| ▸ | HTR2B | P41595 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.51 |
| ▸ | CNR1 | P21554 | 2/20 | 0.49 |
| ▸ | CNR2 | P34972 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31290761 | 0.98 | TLR8 (0.63) | TLR8PPARGPPARALTA4HTSHR | |
| SCHEMBL1237415 | 0.96 | TLR8 (0.60) | TLR8PPARGPPARALTA4HTSHR | |
| SCHEMBL6473617 | 0.96 | TLR8 (0.60) | TLR8PPARGPPARALTA4HTSHR | |
| SCHEMBL2477207 | 0.96 | TLR8 (0.60) | TLR8PPARGPPARALTA4HTSHR | |
| SCHEMBL30844101 | 0.96 | TLR8 (0.60) | TLR8PPARGPPARALTA4HTSHR | |
| SCHEMBL4250155 | 0.96 | TLR8 (0.60) | TLR8PPARGPPARALTA4HTSHR | |
| SCHEMBL27768841 | 0.92 | TLR8 (0.62) | TLR8PPARGPPARALTA4HMAPT | |
| SCHEMBL347826 | 0.88 | TLR8 (0.58) | TLR8PPARGPPARALTA4HMAPT | |
| SCHEMBL9425423 | 0.88 | TLR8 (0.64) | TLR8PPARGPPARALTA4HTSHR | |
| SCHEMBL11693360 | 0.88 | TLR8 (0.56) | TLR8PPARGPPARALTA4HTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-8048982-B2 | Method for producing aromatic compound polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| EP-2241547-A1 | Method for producing aromatic compound polymer | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| EP-2241548-A1 | Vanadium di-nuclear complex | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-1767560-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | Sumitomo Chemical Company, Limited (JP) | 2007-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | PAH, MAOA, AHR | TLR8 2756/4885PPARG 51/4885PPARA 39/4885 |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | PAH, MAOA, AHR | TLR8 2779/4885PPARG 54/4885PPARA 40/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.